A005500 Stock Overview
Samjin Pharmaceuticals Co., Ltd. manufactures and sells medicine.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Samjin Pharmaceuticals Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩19,800.00 |
| 52 Week High | ₩25,000.00 |
| 52 Week Low | ₩19,370.00 |
| Beta | 0.31 |
| 1 Month Change | -1.98% |
| 3 Month Change | -3.41% |
| 1 Year Change | -13.35% |
| 3 Year Change | -25.56% |
| 5 Year Change | -45.15% |
| Change since IPO | 587.75% |
Recent News & Updates
Recent updates
Shareholder Returns
| A005500 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 0.6% | 2.6% | 0.8% |
| 1Y | -13.3% | 6.8% | 6.3% |
Return vs Industry: A005500 underperformed the KR Pharmaceuticals industry which returned 6.8% over the past year.
Return vs Market: A005500 underperformed the KR Market which returned 6.3% over the past year.
Price Volatility
| A005500 volatility | |
|---|---|
| A005500 Average Weekly Movement | 1.5% |
| Pharmaceuticals Industry Average Movement | 4.5% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in KR Market | 11.7% |
| 10% least volatile stocks in KR Market | 2.3% |
Stable Share Price: A005500 has not had significant price volatility in the past 3 months.
Volatility Over Time: A005500's weekly volatility (1%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | n/a | Yong-Joo Choi | www.samjinpharm.co.kr |
Samjin Pharmaceuticals Co., Ltd. manufactures and sells medicine. It offers medicine in oral, drop, and injecting forms. The company provides over-the-counter medicines, such as Gevorin, an anti-infalammatory pain killer; Trestan, an appetite stimulant; Flaris, an anti-thrombotic agent; and Nutilin, a brain function improvement agent, as well as medicine for treatment of chronic diseases.
Samjin Pharmaceuticals Co., Ltd. Fundamentals Summary
| A005500 fundamental statistics | |
|---|---|
| Market cap | ₩252.94b |
| Earnings (TTM) | ₩21.89b |
| Revenue (TTM) | ₩274.03b |
11.6x
P/E Ratio0.9x
P/S RatioIs A005500 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A005500 income statement (TTM) | |
|---|---|
| Revenue | ₩274.03b |
| Cost of Revenue | ₩156.30b |
| Gross Profit | ₩117.73b |
| Other Expenses | ₩95.84b |
| Earnings | ₩21.89b |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.71k |
| Gross Margin | 42.96% |
| Net Profit Margin | 7.99% |
| Debt/Equity Ratio | 31.5% |
How did A005500 perform over the long term?
See historical performance and comparison